Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial 99mTc-MIBI SPECT and 18F-FDG PET

Journal of Nuclear Medicine

Volumn 42, Issue 8, 2001, Pages 1166-1173

  Zhang, X ^a   Liu, X J ^a   Wu, Q ^a   Shi, R ^a   Gao, R ^a   Liu, Y ^a   Hu, S ^a   Tian, Y ^a   Guo, S ^a   Fang, W ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Myocardial viability; PET; Prognosis; SPECT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEART; HEART ANEURYSM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0034894331     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Specialized centers for heart failure management
2. Radionuclide tracers in the evaluation of resting myocardial ischemia and viability
3. Identification of viable myocardium
4. 99mTc-MIBI SPET: A comparative study in patients with coronary artery disease
5. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxy-isobutyl-isonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease
6. 18F-FDG PET in assessing myocardial viability
7. 18F-FDG PET in patients with myocardial infarction
8. Recovery of regional left ventricular dysfunction after coronary revascularization: Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography
9. 99mTc-sestamibi SPECT
10. Value metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
11. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: Relative efficacy of medical therapy and revascularization
12. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
13. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure
14. Coronary revascularization for postischemic heart failure: How myocardial viability affects survival
15. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging
16. Long-term survival of medically treated patients in Coronary Artery Surgery Study (CASS)
17. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
18. Summary of a consensus concerning death and ischemic events after coronary artery bypass surgery
19. Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: A follow-up study
20. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: Comparison with stress thallium imaging
21. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy
22. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions
23. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease
24. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine-18-fluorodeoxyglucose positron emission tomography imaging
25. Hibernating myocardium requires timely revascularization
26. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography